Remove Food and Drug Administration Remove Side effects Remove Training
article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). Approximately 40 million people in the US experience Type I allergic reactions due to food, venom or insect stings, 4 and the numbers are similar in Europe. What are the main advantages of EURneffy over similar treatments?

article thumbnail

Psilocybin-assisted therapy reduces depressive symptoms in cancer patients

European Pharmaceutical Review

Treatment-related side effects included nausea and headache but were generally mild. “As Psilocybin-assisted therapy Psilocybin-assisted therapy combines psilocybin with psychological support from trained therapists.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. The pharmacist can then review their medical history to make sure there are no concerns of drug-drug interactions with Paxlovid.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. The CAR T cells need to persist in the blood to expand and elicit maximal effect, and there is a correlation between expansion and persistence and response. Furthermore, point-of-care CAR T-cell manufacturing provides clinical benefits.

article thumbnail

Pharmaceutical Marketing Strategies: How to Effectively Promote Your Brand

Pharma Marketing Network

Marketers must adhere to regulations set forth by bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe. Pharmaceutical marketers must provide truthful and non-misleading information about their products, including potential risks and side effects.

article thumbnail

Direct to Patient Healthcare

Healthcare Success

Lee Aase: As a way of, you know, kind of in keeping with how the Mayo Brothers had done old fashioned analog, social networking in the 1920s, 1930s, visiting lots of countries when they had to go by ship and by air airplane and trained to get there. I'm like, it's controlled drugs. And like you could broadcast without an FCC license.

article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.